Lv21
158 积分 2022-03-30 加入
Hallmarks of liver cancer: Therapeutic implications
15天前
已完结
TACE and tyrosine kinase inhibitors with or without PD-1 inhibitors as first-line therapy for intermediate-advanced HCC: a multicenter real-world cohort study
21天前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
21天前
已完结
Portal supply of seg‐ ment Ⅳ of the liver based on CT‐scan[J]. Surg Radiol Anat, 2017,39(5):471‐476
1个月前
已完结
NTRK fusions in thyroid cancer: Pathology and clinical aspects
10个月前
已完结
Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: An individual patient data meta-analysis
10个月前
已完结
RET fusion rather than BRAF mutation confers a higher risk of aggressiveness and recurrence in papillary thyroid carcinoma
10个月前
已完结
RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype
10个月前
已完结
皖公网安备34019202002308
